Skip to main content

Cogent Biosciences, Inc. insider trading

COGTNASDAQ
$30.14-0.24 (-0.79%)as of Oct 7, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 7, 2025 to Oct 7, 2026. Price (+95.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flow

Key players

  • FFFairmount Funds Management LLCDirector3.1715%of company
  • ARAndrew R. RobbinsPresident and CEO0.3789%of company
  • CPCole PinnowChief Commercial Officer0.1249%of company
  • JEJohn Edward RobinsonChief Scientific Officer0.0807%of company
  • JSJessica SachsChief Medical Officer0.0772%of company
  • JLJohn L. GreenChief Financial Officer0.076%of company
  • EKEvan KearnsChief Legal Officer0.063%of company
  • AMArlene MorrisDirector0.00%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
COGTFairmount Funds Management LLCDirectorOpen market sell$243M-56.0%$34.66$243MMar 31, 2026Mar 31, 2026
COGTFairmount Funds Management LLCDirectorOpen market sell$127M-38.9%$36.40$127MJan 22, 2026Jan 22, 2026
COGTEvan KearnsChief Legal OfficerOpen market sell$2.52M-37.3%$38.70$2.52MDec 26, 2025Dec 30, 2025
COGTJohn L. GreenChief Financial OfficerOpen market sell$2.98M-36.9%$38.68$2.98MDec 26, 2025Dec 30, 2025
COGTJessica SachsChief Medical OfficerOpen market sell$3.2M-38.2%$38.70$3.2MDec 26, 2025Dec 30, 2025
COGTJohn Edward RobinsonChief Scientific OfficerOpen market sell$3.49M-39.1%$38.74$3.49MDec 26, 2025Dec 30, 2025
End of history · 6 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.